French Health Spending Moderates

10 February 1997

In France, signs are that doctors' spending on treatments andprescriptions rose 2.3% in 1996 against a growth target of 2.1%, says the CNAM fund. 1996 began with spending growth of about 4%, but spending is reckoned to have either stagnated or actually fallen since June 1996.

The CNAM says a 2.3% spending rise corresponds to a 2% trend for general practice medicine and 3% for specialists.

While there is considerable relief that spending has not repeated 1995's trend, when it rose 4.7% against a 3.3% target, Richard Bouton, president of the doctors' organization MG France, says victory should not be declared too soon; there is a risk of a resurgence in spending if health fund reforms are not put in place quickly.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight